Cigna Investments’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.76M | Sell |
3,509
-84
| -2% | -$40.3K | 0.23% | 73 |
|
|
2026
Q1 | $1.77M | Sell |
3,593
-57
| -2% | -$30.9K | 0.27% | 65 |
|
|
2025
Q4 | $2.12M | Sell |
3,650
-45
| -1% | -$25.4K | 0.31% | 48 |
|
|
2025
Q3 | $1.79M | Hold |
3,695
| – | – | 0.25% | 61 |
|
|
2025
Q2 | $1.5M | Sell |
3,695
-130
| -3% | -$54.4K | 0.25% | 72 |
|
|
2025
Q1 | $1.9M | Sell |
3,825
-84
| -2% | -$45.5K | 0.35% | 47 |
|
|
2024
Q4 | $2.03M | Sell |
3,909
-21
| -0.5% | -$11.5K | 0.36% | 43 |
|
|
2024
Q3 | $2.43M | Sell |
3,930
-29
| -0.7% | -$17.2K | 0.43% | 34 |
|
|
2024
Q2 | $2.19M | Sell |
3,959
-136
| -3% | -$77.9K | 0.41% | 37 |
|
|
2024
Q1 | $2.38M | Sell |
4,095
-16
| -0.4% | -$8.98K | 0.45% | 36 |
|
|
2023
Q4 | $2.18M | Sell |
4,111
-23
| -0.6% | -$11.1K | 0.45% | 40 |
|
|
2023
Q3 | $2.09M | Sell |
4,134
-550
| -12% | -$293K | 0.48% | 32 |
|
|
2023
Q2 | $2.44M | Sell |
4,684
-73
| -2% | -$39.4K | 0.45% | 38 |
|
|
2023
Q1 | $2.74M | Sell |
4,757
-101
| -2% | -$56.9K | 0.54% | 31 |
|
|
2022
Q4 | $2.68M | Buy |
4,858
+35
| +0.7% | +$18.5K | 0.56% | 31 |
|
|
2022
Q3 | $2.45M | Sell |
4,823
-246
| -5% | -$138K | 0.54% | 32 |
|
|
2022
Q2 | $2.75M | Sell |
5,069
-1,890
| -27% | -$1.04M | 0.55% | 33 |
|
|
2022
Q1 | $4.11M | Sell |
6,959
-1,976
| -22% | -$1.14M | 0.5% | 35 |
|
|
2021
Q4 | $5.96M | Sell |
8,935
-3,173
| -26% | -$1.98M | 0.47% | 32 |
|
|
2021
Q3 | $6.92M | Sell |
12,108
-245
| -2% | -$134K | 0.52% | 31 |
|
|
2021
Q2 | $6.23M | Sell |
12,353
-1,845
| -13% | -$871K | 0.44% | 39 |
|
|
2021
Q1 | $6.48M | Buy |
14,198
+280
| +2% | +$134K | 0.45% | 43 |
|
|
2020
Q4 | $6.48M | Buy |
13,918
+1,061
| +8% | +$497K | 0.5% | 39 |
|
|
2020
Q3 | $5.68M | Sell |
12,857
-18
| -0.1% | -$7.44K | 0.55% | 36 |
|
|
2020
Q2 | $4.67M | Buy |
12,875
+1,565
| +14% | +$525K | 0.44% | 44 |
|
|
2020
Q1 | $3.21M | Buy |
11,310
+650
| +6% | +$205K | 0.41% | 49 |
|
|
2019
Q4 | $3.34M | Sell |
10,660
-1,135
| -10% | -$344K | 0.35% | 58 |
|
|
2019
Q3 | $3.56M | Buy |
11,795
+470
| +4% | +$135K | 0.37% | 51 |
|
|
2019
Q2 | $3.15M | Sell |
11,325
-309
| -3% | -$85.1K | 0.34% | 58 |
|
|
2019
Q1 | $3.18M | Sell |
11,634
-220
| -2% | -$54.8K | 0.35% | 60 |
|
|
2018
Q4 | $2.65M | Buy |
11,854
+38
| +0.3% | +$8.92K | 0.22% | 61 |
|
|
2018
Q3 | $2.76M | Sell |
11,816
-921
| -7% | -$212K | 0.22% | 67 |
|
|
2018
Q2 | $2.64M | Sell |
12,737
-2,000
| -14% | -$425K | 0.19% | 75 |
|
|
2018
Q1 | $3.04M | Sell |
14,737
-96
| -0.6% | -$20.1K | 0.2% | 69 |
|
|
2017
Q4 | $2.82M | Sell |
14,833
-479
| -3% | -$91.8K | 0.18% | 79 |
|
|
2017
Q3 | $2.9M | Buy |
15,312
+134
| +0.9% | +$24.3K | 0.19% | 74 |
|
|
2017
Q2 | $2.65M | Sell |
15,178
-1,091
| -7% | -$183K | 0.18% | 81 |
|
|
2017
Q1 | $2.5M | Buy |
16,269
+1,730
| +12% | +$264K | 0.17% | 89 |
|
|
2016
Q4 | $2.05M | Buy |
+14,539
| New | +$2.14M | 0.22% | 94 |
|
Other funds holding TMO
Cigna Investments's TMO Position: Q2 2026 in Review
Cigna Investments reduced its Thermo Fisher Scientific (TMO) stake by 2.3% in Q2 2026, selling an estimated $40.3K and leaving 3,509 shares worth $1.76M. The position accounts for 0.23% of the portfolio, ranked #73.
Cigna Investments first reported a position in TMO in Q4 2016 and has held it in 39 quarters since. The position peaked at $6.92M in Q3 2021. 2,609 funds tracked by Wall St. Rank hold TMO as of Q2 2026.
- Cigna Investments held 3,509 shares of Thermo Fisher Scientific worth $1.76M as of Q2 2026.
- Cigna Investments sold 84 Thermo Fisher Scientific shares in Q2 2026, an estimated $40.3K.
- Thermo Fisher Scientific made up 0.23% of Cigna Investments's portfolio in Q2 2026, its #73 holding.
- Cigna Investments first reported a position in Thermo Fisher Scientific in Q4 2016 and has held it in 39 quarters since.
- Cigna Investments's Thermo Fisher Scientific position peaked at $6.92M in Q3 2021.
- 2,609 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.
Based on Cigna Investments's 13F filing for Q2 2026, filed 21 Jul 2026.